Bishal Gyawali: Pleased to represent Queen’s Health Sciences into the FASCO directory
Bishal Gyawali, Associate Professor at Queen’s University, shared a post by ASCO on X, adding:
“Thank you, ASCO for this honour.
Very pleased to be in such a great company of colleagues, and to represent Queen’s Health Sciences, Sinclair Cancer Research Institute, Ontario Institute for Cancer Research (OICR), and Nepal into the FASCO directory.”
Quoting ASCO’s post:
“Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction this quarter!
We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction.”
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023